Welcome to our dedicated page for Integer Hldgs SEC filings (Ticker: ITGR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Integer Holdings Corporation SEC filings document the disclosures of a NYSE-listed medical device CDMO with common stock trading under ITGR. Recent 8-K reports furnish quarterly and annual operating results, earnings-call materials, Regulation FD updates, capital-allocation actions, and material corporate events tied to the company’s medical device manufacturing business.
The filing record also covers governance and ownership matters, including definitive proxy materials, board composition, executive and director changes, committee assignments, compensation disclosures, shareholder meeting items, and cooperation-agreement terms with an investor group. These documents also disclose capital structure items such as common-stock registration details and share repurchase authorization.
Integer Holdings Corporation furnished an 8‑K announcing its results for the third quarter ended September 26, 2025. The company issued a press release and updated its earnings conference call slide presentation, which will be referenced during the call and made available on its website.
The materials are furnished under Items 2.02 and 7.01, not filed, with the press release included as Exhibit 99.1.
On 24 July 2025, Integer Holdings Corporation (NYSE: ITGR) filed a Form 8-K to furnish, rather than file, information under Items 2.02 and 7.01.
- Item 2.02 — Results of Operations and Financial Condition: the company issued a press release announcing financial results for the quarter ended 27 June 2025, attached as Exhibit 99.1.
- Item 7.01 — Regulation FD Disclosure: an updated earnings-call slide deck will be available in the Investor Relations section of its website and referenced during the call.
The filing does not contain any quantitative results, guidance, or other financial metrics. All information is expressly furnished and is therefore not subject to Section 18 liability, nor is it incorporated by reference into Securities Act filings unless specifically stated.
Integer Holdings Corporation (ITGR) filed a Form 4 indicating that director Michael J. Coyle received a grant of 1,355 restricted stock units (RSUs) on 07/10/2025. Each RSU converts into one share of common stock and vests in four roughly equal installments on Aug 21 2025, Nov 21 2025, Feb 21 2026, and May 19 2026. The award was recorded at a price of $0, reflecting standard equity compensation rather than an open-market purchase. Following the grant, Coyle directly holds 1,355 ITGR shares. No derivative securities, sales, or additional transactions were reported, suggesting the filing represents routine director compensation rather than a signal of insider sentiment.